
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has seen an upward revision in normalized Funds From Operations (NFFO) estimates due to stronger-than-expected performance in the second quarter of 2025, alongside a positive outlook communicated by management. The updated projections indicate a 2025 normalized FFO estimate of $4.80 per share, aligning with management’s guidance and exceeding the consensus estimate, contributing to an optimistic financial forecast. Additionally, the 2026 FFO estimate has been raised to $5.03 per share, surpassing market expectations, which further supports a favorable assessment of the company's financial outlook.
Bears say
National Health Investors Inc. faces a negative outlook primarily due to expected lower earnings growth over the next few years, driven by the challenges associated with operator transitions and issues. Concerns over potential lower-than-anticipated rent resets from NHC and risks related to deferred rent collections heighten the company's vulnerability to market fluctuations. Additionally, the possibility of operator challenges, exacerbated by factors such as pandemic-related impacts, further underscores the financial risks facing the REIT.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares